Tags |
|
|
Links |
|
|
Digg It - 10 Cons Of An International Credit Card
Credit card fraud is a fast increasing crime in the world. International Credit Card holders are mostly the victims of this unauth
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
orized access to their accounts. Let’s take a closer look of the problems faced by international credit cards.
1. Repetitive use
1. Repetitive use
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
of credit card numbers. After a credit card number has been used and disregarded, say cancelled, credit card companies would reiss
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ue the same number to other cardholders. The personal identification numbers (PIN) is changed as well as the credit cardholder’s p
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
rsonal information. But it still bears the same credit card number.
2. Low standards when it comes to the use of cards by the par
2. Low standards when it comes to the use of cards by the par
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ticipating merchants. This is a common problem encountered by international credit cardholders. Employees of the participating mer
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
chants have the full access to the account number as well as the security number of the card.
3. Account Statements given out by
3. Account Statements given out by
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
credit card companies contains less information about the participating merchant. It does not include relevant information about t
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
e vendor that charged any transaction on the credit card.
4. Unreliable blocking functions. Once a card loss is reported, it will
4. Unreliable blocking functions. Once a card loss is reported, it will
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
still take months for the credit card companies to block the transactions being made through the stolen or lost credit card.
5.
5.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
Lack of validation software. Participating vendors should have better validation software installed on their computer system.
6.
6.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
Consumer unfriendly policies on fraud management. The policies on the present fraud management take the blame on the cardholders t
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ough not directly stipulated. This means that the policies on the fraud management of international credit card companies protect
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
not the consumers but the company.
7. Lax standards on investigation about fraudulent transactions. This is the sad part for the
7. Lax standards on investigation about fraudulent transactions. This is the sad part for the
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
victims of fraud through their credit cards. Getting the suspects charged though proven guilty of fraud seems to take on slowly.
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
8. Credit card fraud is usually committed through online transactions. This means that credit cardholders are not protected with t
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
e authorized or unauthorized use of their cards on purchases or services paid online.
9. Most of the companies that typically app
9. Most of the companies that typically app
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ear on charges are those associated with pornography industry. These companies are the ones that accept transactions even without
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
verifying the cardholder’s information.
10. Most of the banks’ system is not compatible with other international credit card comp
10. Most of the banks’ system is not compatible with other international credit card comp
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
anies for the e-commerce. This is a potential weakness that would mean loss of clients so they would prefer to keep quiet about it
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/91683/diggit-10-Cons-Of-An-International-Credit-Card.html">10 Cons Of An International Credit Card</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/91683/diggit-10-Cons-Of-An-International-Credit-Card.html]10 Cons Of An International Credit Card[/url]
Related Articles:
What Does the Back of Your Business Card Say?
How Trustworthy is Your Organisation?
Bookmark it:
|